4th Protein Kinases in Drug Discovery

Venue: Boston

Location: Boston, Massachusetts, United States

Event Date/Time: May 04, 2009 End Date/Time: May 05, 2009
Registration Date: May 05, 2009
Early Registration Date: Apr 04, 2009
Report as Spam


With only eight small molecule kinase inhibitors now approved on the market and 500 additional kinase inhibitors in the discovery and preclinical phases, protein kinase drugs are poised to become the next blockbusters of the future. It will require you to stay abreast with recent technological advancements and development trends to remain competitive in the current market climate.

GTCbio is proud to present you with the 4th Annual Protein Kinases in Drug Discovery Conference! This meeting, taking place on May 4-5, 2009 in Boston, MA, will bring together industry leaders from big pharma, biotech companies, academia, and government, to provide you with a solid primer for a better understanding of the complex activities of kinases and some solutions to the challenges associated with kinase drug development. We will explore current drug design trends and strategies to overcome issues such as selectivity, pathway crosstalk, drug resistance and others. On the second day of the conference, you will be treated to updates on novel tyrosine, serine/threonine, and lipid kinase inhibitors along with their different applications to treat oncology, inflammation and central nervous system disorders. The meeting will offer you the intimate forum to engage in discourse with other distinguished researchers involved in the most cutting-edge kinase work!

The conference features the following sessions:

I: Drug Design Trends - Structure / Selectivity / Pathway
II: Overcoming Challenges of Kinase Drug Development
III: Validated Kinase Targets from Pre-Clinical Studies to Clinical Trials
IV: Novel Kinases and Inhibitor Candidates